<DOC>
	<DOCNO>NCT02474017</DOCNO>
	<brief_summary>To confirm robustness CRC749 inhaler .</brief_summary>
	<brief_title>An Open Study Assess Robustness CRC749 Inhaler</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Males female least 12 year age . 2 . A clinical diagnosis least 12 week prior screen asthma COPD stable treatment . 3 . Spirometry follow salbutamol show FEV1 ≥40 % predict normal FEV1/FVC ratio &lt; 0.7 COPD subject . 4 . Spirometry without salbutamol show FEV1 ≥50 % predict normal asthma subject . 5 . Ability use CRC749 inhaler . 1 . Other chronic active respiratory disorder symptom , treatment COPD asthma exacerbation 28 day precede screening . 2 . History long QT syndrome screen ECG QTcF great 480 millisecond . 3 . Current evidence , history within 6 month prior screen unstable ischemic heart disease , NYHA Class III/IV leave ventricular failure , myocardial infarction . 4 . Subjects Advair ( R ) Diskus ( R ) / Seretide ( R ) Accuhaler ( R ) contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Inhaler</keyword>
	<keyword>Adolescent</keyword>
</DOC>